In this work, by using the samples from PM patients and the EAM model, we found that TLR4 signaling may play a crucial role in triggering the inflammation of PM, and this process required the involvement of TLR4-mediated IFN-γ and IL-17A (Figure S2 in Supplementary Material). The gene discussed is IFNG; the disease is polymyositis.